Michael Horner to Middle Aged
This is a "connection" page, showing publications Michael Horner has written about Middle Aged.
Connection Strength
0.448
-
Five-factor structure of the RBANS is supported in an Alzheimer's disease sample: Implications for validation of neuropsychological assessment instruments. Appl Neuropsychol Adult. 2020 May-Jun; 27(3):232-242.
Score: 0.045
-
An Intervention to Decrease the Occurrence of Invalid Data on Neuropsychological Evaluation. Arch Clin Neuropsychol. 2017 Mar 01; 32(2):228-237.
Score: 0.040
-
Psychological characteristics of individuals who put forth inadequate cognitive effort in a secondary gain context. Arch Clin Neuropsychol. 2014 Dec; 29(8):754-66.
Score: 0.034
-
[Formula: see text]inadequate effort on neuropsychological evaluation is associated with increased healthcare utilization. Clin Neuropsychol. 2014; 28(5):703-13.
Score: 0.033
-
Attentional functioning in patients with posttraumatic stress disorder: a preliminary study. CNS Spectr. 2013 Apr; 18(2):90-4.
Score: 0.030
-
Predictors of psychological symptoms 1 year after traumatic brain injury: a population-based, epidemiological study. J Head Trauma Rehabil. 2008 Mar-Apr; 23(2):74-83.
Score: 0.022
-
Convergent and divergent validity of the Gordon Diagnostic System in adults. Arch Clin Neuropsychol. 2007 Jan; 22(1):37-44.
Score: 0.020
-
Abbreviated form of the test of memory malingering. Int J Neurosci. 2006 Oct; 116(10):1181-6.
Score: 0.020
-
Self-reported psychosocial health among adults with traumatic brain injury. Arch Phys Med Rehabil. 2006 Jul; 87(7):953-61.
Score: 0.019
-
Relationship of the Wender Utah Rating Scale to objective measures of attention. Compr Psychiatry. 2005 Nov-Dec; 46(6):468-71.
Score: 0.018
-
Patterns of alcohol use 1 year after traumatic brain injury: a population-based, epidemiological study. J Int Neuropsychol Soc. 2005 May; 11(3):322-30.
Score: 0.018
-
Construct validity of the Babcock Story Recall Test. Appl Neuropsychol. 2002; 9(2):114-6.
Score: 0.014
-
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952.
Score: 0.013
-
Self-report and objective measures of cognitive deficit in patients entering substance abuse treatment. Psychiatry Res. 1999 May 31; 86(2):155-61.
Score: 0.012
-
Temporal lobe epilepsy and performance on the Wisconsin Card Sorting Test. J Clin Exp Neuropsychol. 1996 Apr; 18(2):310-3.
Score: 0.009
-
A comparison of four embedded validity indices for the RBANS in a memory disorders clinic. Arch Clin Neuropsychol. 2015 May; 30(3):207-16.
Score: 0.009
-
CE hospital service utilization is reduced following neuropsychological evaluation in a sample of U.S. veterans. Clin Neuropsychol. 2013; 27(5):750-61.
Score: 0.008
-
A pilot trial of neuropsychological evaluations conducted via telemedicine in the Veterans Health Administration. Telemed J E Health. 2012 Nov; 18(9):662-7.
Score: 0.007
-
Intact cognition in depressed elderly veterans providing adequate effort. Arch Clin Neuropsychol. 2011 Apr; 26(3):184-93.
Score: 0.007
-
Embedded indices of effort in the repeatable battery for the assessment of neuropsychological status (RBANS) in a geriatric sample. Clin Neuropsychol. 2010 Aug; 24(6):1064-77.
Score: 0.006
-
Pre-existing health conditions and repeat traumatic brain injury. Arch Phys Med Rehabil. 2009 Nov; 90(11):1853-9.
Score: 0.006
-
A population-based study of repetitive traumatic brain injury among persons with traumatic brain injury. Brain Inj. 2009 Oct; 23(11):866-72.
Score: 0.006
-
Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat. 2009 Dec; 37(4):328-34.
Score: 0.006
-
A preliminary controlled trial of divalproex in posttraumatic stress disorder. Ann Clin Psychiatry. 2009 Apr-Jun; 21(2):89-94.
Score: 0.006
-
Factor analysis of the Repeatable Battery for the Assessment of Neuropsychological Status. Appl Neuropsychol. 2008; 15(4):274-9.
Score: 0.005
-
Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. Schizophr Res. 2008 Apr; 101(1-3):142-51.
Score: 0.005
-
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. Schizophr Res. 2007 Jul; 93(1-3):131-5.
Score: 0.005
-
Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. Int J Neuropsychopharmacol. 2006 Oct; 9(5):603-5.
Score: 0.005
-
Decreased cortical response to verbal working memory following sleep deprivation. Sleep. 2005 Jan; 28(1):55-67.
Score: 0.004
-
Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Neurocase. 2003 Jun; 9(3):274-82.
Score: 0.004
-
The trail making test, part B: cognitive flexibility or ability to maintain set? Appl Neuropsychol. 2002; 9(2):106-9.
Score: 0.004
-
The construct validity and clinical utility of the Frank Jones story as a brief screening measure of cognitive dysfunction. Psychosomatics. 2001 Mar-Apr; 42(2):146-9.
Score: 0.003
-
Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions. J Gen Intern Med. 1996 Oct; 11(10):597-607.
Score: 0.002